's Information

Name Jung-Min Ahn
Country Korea (South)
Job Interventional Cardiologist

Other summitMD.com content(s) by This

Cases

  1. Transcatheter Aortic Valve Replaceement with the Edwards SAPIEN 3 Valve in a Patient with Severe Aortic Stenosis
  2. Transcatheter Aortic Valve Replacement with Edwards SAPIEN 3 Valve under Moderate Sedation
  3. Transcatheter Aortic Valve Replacement(TAVR) with EVOLUT-R in a Patient with Severe Paravalvular Leakage after Previous TAVR
  4. Transcatheter Aortic Valve Implantation with the Edwards SAPIEN 3
  5. Transcatheter Aortic Valve Replacement with LotusTM Valve
  6. LM Bifurcation Stenting with Crush Technique
  7. Hybrid BVS + DES Stenting at a Complex Lesion
  8. LM Bifurcation Stenting with Crush Technique
  9. Stent Delivery to Using Guidezilla
  10. Diffusely Calcified Long Lesion Treated Using Rotablation
  11. Diffusely Calcified Long Lesion Treated Using Rotablation
  12. In-Stent Restenosis of Undersized Stent at LM, LAD and LCX
  13. Valve-in-Valve Transcatheter Aortic Valve Replacement with Evolut R
  14. PCI in a Patient with Anomalous Origin of LMCA Arising from RCA
  15. LM Bifurcation and LAD Bifurcation Stenting with the Crush Technique
  16. V Stenting Technique to Severely Calcified ISR Lesions in Trifurcation with Protected LAD

Slide Presentations

  1. Does the Timing of IABP Matter?
  2. FFR Guided Functional Angioplasty
  3. Two Cases with Coronary Thromboembolism
  4. FFR-guided PCI in Tandem Lesion
  5. Long Lesion and Tandem Lesion
  6. Promus Element Clinical Program in Asan Medical Center
  7. FFR Utilization in LM PCI
  8. New-generation DES for Long Lesions: From a Large-scale Cohort Regis
  9. Novice's Trial of Complex LM PCI
  10. Impact of Functional Angioplasty on Clinical Outcomes of PCI
  11. Case Presentation: Functional Angioplasty
  12. Anatomical - Functional Stenosis: How Much Discordant?
  13. Comparison of Platinum Chromium Versus Cobalt Chromium Everolimus-eluting Stent in Real World Practice: Outcomes from the Multicenter Prospective IRIS-DES Registry
  14. Cross and Perfect: 2013 Update
  15. IRIS-ELEMENT Data Review
  16. LM PCI
  17. Clinical Evidence of Neoatherosclerosis: ISR and Late Stent Thrombosis
  18. VH IVUS: Native Plaque and Neointima
  19. LM & Tandem Lesion
  20. Case-based Review: Incidence and Treatment of LM ISR
  21. Clinical Implementation of FFR
  22. Comparison of Coronary Bypass Surgery with Drug-eluting Stenting for the Treatment of Left Main Disease: 3-year Follow-up of the PRECOMBAT Trial
  23. Is There a Generation Gap of DES: Results of PRECOMBAT Study Series
  24. FFR-guided PCI in Routine Practice: Learn from AMC Experiences
  25. TAVI for Bicuspid Valve Stenosis
  26. Understanding About Visual-Functional Mismatching
  27. Left Main PCI
  28. Complex Lesions, Left Main, Bifurcations, Tandem, and More
  29. Preliminary Data from IRIS FFR Registry
  30. Randomzed Trial of Stents Versus Bypass Surgery for Left Main Coronary Artery Disease: Five-Year Outcomes of the PRECOMBAT Study
  31. Readmission After PCI or CABG
  32. Case Presentation 4: Medically Stabilized Type A Aortic Dissection After TAVI
  33. Comparative Outcomes of Various DES from IRIS-MAIN Registry and PRECOMBAT Series
  34. Final Answer RESTORE
  35. TAVR for Bicuspid AV: Tips and Tricks
  36. Left Main
  37. Integrated Use of IVUS and FFR in Real Practice
  38. Tandem Lesion Evaluation
  39. [Review in 2015] Physiology
  40. LM PCI 2016: Integrated Approach Using IVUS, FFR and New Imaging Modality
  41. Elderly Population
  42. Fate of FFR-Guided Deferral Data from IRIS-FFR Registry
  43. Practical Aspect of IMR in AMI and Stable Angina
  44. Prognostic Value of FFR: Insight from IRIS-FFR Registry
  45. Bicuspid TAVR Registry
  46. Tandem
  47. Clinical Impact of Routine FFR Measurement
  48. Current Status of TAVR: High/Intermediate and Lower Risk
  49. AP TAVR Registry
  50. Utility of Intravascular Imaging for Resolving Issues During PCI
  51. Left Main and MVD PCI: Imaging and Functional Guidance
  52. Clinical Outcome of DEFER
  53. Bicuspid and Valve-in-Valve; How Different?
  54. TAVR: Bicuspid, Severe Calcium, and Low Lying Left Main
  55. Bicuspid TAVR Registry and TRANSIT Trial: TAVI Experience in AMC
  56. Integrated Use of FFR and IVUS for LM PCI
  57. Bicuspid AS: Future Perspectives of TAVR
  58. [Taped Case] TAVR with Evolut R
  59. TAVR for Bicuspid Valve: Clinical Outcome and Technical Considerations
  60. Asian Pacific TAVR Registry
  61. The Benefit of Complete Revascularization in Complex Coronary Artery Disease
  62. Five-Year Outcomes of Routine FFR Use in Clinical Practice: Data from ASAN PCI Registry
  63. FFR as the Gold Standard Index!
  64. [Case #2: Transcatheter Aortic Valve Implantation in a Patient with Type B Aortic Dissection] Part 2. How Would I Treat?
  65. Distal Left Main Bifurcation PCI: Concept Is More Important.
  66. Impact of Renal Function on Stroke or Systemic Embolism Following TAVR
  67. How About Integrated Use of Resting Pd/Pa and FFR?
  68. TAVR in Bicuspid Aortic Stenosis with Severe Calcification: Case Reviews and Tips-and-Tricks
  69. Expert Case Review: Complex Bifurcation PCI
  70. Expert Case Review: Complex PCI for Severe Calcified Coronary Disease
  71. Guide Extension Catheters: A Strong Support from a Parent-Child Relationship
  72. Synergetic Approach for Discordant Lesions Between FFR and Hyperemia Free Indexes
  73. OAC in TAVR: FAILED GALILEO - NOAC Don\'t Work or Other Options?
  74. Current Status of Balloon-Expandable TAVR in Korea
  75. How Do I Implement?: FFR and Various Non-hyperemic Diastolic Index
  76. Case 1: Unexpanded ISR - Challenging and Optimal Treatment
  77. Clinically Relevant PeriProcedural MI: Practical and Clinical Trial Aspect
  78. [Case-based Debate: Intracoronary Imaging Modalities for PCI Guidance] IVUS Is Better!
  79. Prognosis of Discordant Lesion Between FFR and Hyperemia Free Indexes
  80. The Role of Debulking Atherectomy for Calcific In-stent Restenosis
  81. Bifurcation PCI: Contemporary Practical Approach
CardioVascular Research Foundation (CVRF)
2nd Floor, Asan Institute for Education & Research, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Korea
Tel_82.2.3010.4792 | Fax_82.2.475.6898
ܹ
ǥ̻ ڽ | ı øȷ43 88, ƻ꺴 ƻ걳 2 | ڵϹȣ 215-82-06387
å_ | ȭȣ_02.3010.4792 | ѽȣ_02.475.6898
Copyright © CVRF, Seoul, Korea. All rights reserved.